Palatin Technologies
PTN
#10980
Rank
NZ$15.8 M
Marketcap
NZ$8.88
Share price
1.42%
Change (1 day)
N/A
Change (1 year)

Earnings for Palatin Technologies (PTN)

Earnings in 2026 (TTM): -NZ$10.61 Million

According to Palatin Technologies's latest financial reports the company's current earnings are NZ$12.88 Million. In 2025 the company made an earning of -NZ$17.08 Million, an increase over its 2024 earnings that were of -NZ$47.83 Million. The earnings displayed on this page is the company's Pretax Income.

Earnings history for Palatin Technologies from 1998 to 2026

Annual earnings

Year Earnings Change
2026 (TTM) -NZ$10.61 Million-37.88%
2025 -NZ$17.08 Million-64.29%
2024 -NZ$47.83 Million-16.9%
2023 -NZ$57.56 Million5.99%
2022 -NZ$54.31 Million-13.7%
2021 -NZ$62.93 Million33.25%
2020 -NZ$47.22 Million-172.11%
2019 NZ$65.48 M2352.33%
2018 NZ$2.67 M-94.13%
2017 NZ$45.5 M-154.92%
2016 -NZ$82.85 Million3.67%
2015 -NZ$79.92 Million878%
2014 -NZ$8.18 Million-72.64%
2013 -NZ$29.87 Million-33.11%
2012 -NZ$44.65 Million77.71%
2011 -NZ$25.13 Million
2003 -NZ$42.55 Million29.93%
2002 -NZ$32.75 Million36.18%
2001 -NZ$24.05 Million
1999 -NZ$19.96 Million6.04%
1998 -NZ$18.82 Million

Earnings for similar companies or competitors

Company Earnings Earnings differencediff. Country
Johnson & Johnson
JNJ
NZ$46.52 B-419,974.84%๐Ÿ‡บ๐Ÿ‡ธ USA
AstraZeneca
AZN
NZ$25.44 B-229,711.05%๐Ÿ‡ฌ๐Ÿ‡ง UK
Neurocrine Biosciences
NBIX
NZ$1.45 B-13,209.87%๐Ÿ‡บ๐Ÿ‡ธ USA
MediciNova
MNOV
-NZ$19.09 Million 72.18%๐Ÿ‡บ๐Ÿ‡ธ USA
Ligand Pharmaceuticals
LGND
NZ$0.43 B-4,011.53%๐Ÿ‡บ๐Ÿ‡ธ USA
Dicerna Pharmaceuticals
DRNA
-NZ$0.21 Billion 1,784.89%๐Ÿ‡บ๐Ÿ‡ธ USA
ANI Pharmaceuticals
ANIP
NZ$0.25 B-2,384.53%๐Ÿ‡บ๐Ÿ‡ธ USA
GlycoMimetics
GLYC
-NZ$52.35 Million 372.38%๐Ÿ‡บ๐Ÿ‡ธ USA
Ardelyx
ARDX
-NZ$98.5 Million 788.76%๐Ÿ‡บ๐Ÿ‡ธ USA